Annual Report and Accounts & Notice of AGM

ImmuPharma PLC

Annual Report and Accounts

Notice of Annual General Meeting: 19 May 2011

In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2010, has been posted to shareholders.

The annual report is available, in electronic form, for download on the Company's website www.immupharma.com.

The Company's Annual General Meeting will be held on 19 May 2011 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.

- Ends -

For further information, please contact:

ImmuPharma PLC:

Dr Robert Zimmer, President & Chief Scientific Officer + 33 389 32 76 50

Dimitri Dimitriou, Chief Executive Officer +44 20 7152 4080

Richard Warr, Chairman +44 20 7152 4080

Buchanan Communications

Lisa Baderoon

Mark Court +44 20 7466 5000

Panmure, Gordon & Co., NOMAD & Broker

Andrew Burnett

Rakesh Sharma +44 20 7459 3600

Espirito Santo Investment Bank

James Bromhead

Richard Crawley +44 20 7456 9191